Publications by authors named "Elizabeth Sakach"

Claim this Profile
N
Negative 18F-FES PET/CT Despite Estrogen Receptor Positivity by Immunohistochemistry.
Ismaheel O Lawal, Xiaoxian Li, Elizabeth A Sakach, Clara R Farley, Jane L Meisel

Clin Nucl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Elizabeth A Sakach

JCO Oncol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances of the year: Breast cancer.
Clara R Farley, Elizabeth Sakach, Natalie Ridge, Ruth Sacks, Kevin Kalinsky

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Elizabeth A Sakach

JCO Oncol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
Elizabeth Sakach, Merve Keskinkilic, Sarah Wood, Madison Canning, Kevin Kalinsky

Curr Treat Options Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, Prabhjot S Mundi, Elizabeth Sakach

J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trop-2 as a Therapeutic Target in Breast Cancer.
Elizabeth Sakach, Ruth Sacks, Kevin Kalinsky

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
Elizabeth Sakach, Ruth O'Regan, Jane Meisel, Xiaoxian Li

Clin Breast Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review.
Evan Bryson, Elizabeth Sakach, Urvi Patel, Marley Watson, Kevin Hall

Clin Colorectal Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cancers in one: breast carcinoma with underlying melanoma.
Nicholas A Douville, Elizabeth A Sakach, Elizabeth A Wiewiorowski, William Herlihy, John E Pippen

Proc (Bayl Univ Med Cent)· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis